Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Ebiomedicine|January 6, 2022
Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetesLucy Oldfield, Anthony Evans, Rohith Gopala Rao, et al.
Lab on a Chip|September 13, 2012
Expanding 3D geometry for enhanced on-chip microbubble production and single step formation of liposome modified microbubblesSally A Peyman, Radwa H Abou-Saleh, James R McLaughlan, et al.
Elife|March 7, 2023
Recessive pathogenic variants in MCAT cause combined oxidative phosphorylation deficiencyBryn D Webb, Sara M Nowinski, Ashley Solmonson, et al.
Human Mutation|March 30, 2021
Haploinsufficiency of POU4F1 causes an ataxia syndrome with hypotonia and intention tremorBryn D Webb, Anthony Evans, Thomas P Naidich, et al.
Gynecologic Oncology|May 30, 2018
Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group studyAmina Ahmed, Wei Deng, William Tew, et al.
British Journal of Pharmacology|April 21, 2026
Sodium valproate induces pancreatic injury by disruption of one-carbon metabolismWenhao Cai, Di Wu, Yuying Li, et al.
Cancer Research|May 13, 2020
Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific PropertiesLawrence N Barrera, Anthony Evans, Brian Lane, et al.
The Lancet. Oncology|March 6, 2017
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trialGary Middleton, Daniel H Palmer, William Greenhalf, et al.
Environmental Toxicology and Chemistry|July 21, 2023
Applicability of Chronic Multiple Linear Regression Models for Predicting Zinc Toxicity in Australian and New Zealand FreshwatersJennifer L Stauber, Jennifer Gadd, Gwilym A V Price, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2015
Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes MellitusClaire Jenkinson, Victoria L Elliott, Anthony Evans, et al.
Pageof 5